Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State.

Importance: Many therapies are used to treat COVID-19, the disease caused by the virus SARS-CoV-2, including convalescent plasma. The clinical utility of using 2 units of convalescent plasma for COVID-19 hospitalized patients is not fully understood.

Objective: Many therapies are used to treat COVID-19, the disease caused by the virus SARS-CoV-2, including convalescent plasma.

Provision of COVID-19 Convalescent Plasma in a Resource-Constrained State.

Background: Arkansas is a rural state of 3 million people. It is ranked fifth for poverty nationally. The first case of coronavirus disease 2019 (COVID-19) in Arkansas occurred on 11 March 2020.